有针对性的温度管理可以通过抑制铁亡来缓解复苏后心肌功能障碍
Yingying Zhang1,2, Weiwei Du1,2, Ting Kong2,3
1Department of Cardiology, the Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.
Cell death discovery
|February 21, 2025
概括
33°C的有针对性的温度管理 (TTM) 通过减少心肌损伤,显著改善了心脏骤停幸存者的结果. 这种低温策略与德菲洛克萨明一起,通过Nrf2激活和铁调节来保护铁.
科学领域:
- 心脏病学 心脏病学
- 生物化学 生物化学
- 细胞生物学 细胞生物学
背景情况:
- 针对性温度管理 (TTM) 对心脏骤停的幸存者至关重要,以防止心肌复苏后功能障碍 (PRMD).
- 对于TTM的最佳温度及其缓解心肌缺血/再输 (I/R) 损伤的潜在机制仍在争论中.
- 心肌I/R损伤涉及复杂的细胞过程,包括氧化应激和铁失调.
研究的目的:
- 研究TTM在不同温度 (33°C与36°C) 中对缓解PRMD的疗效.
- 阐明TTM和德菲洛克萨 (DFO) 保护心肌损伤的分子机制.
- 探索铁恒温,铁和Nrf2激活在TTM保护作用中的作用.
主要方法:
- 心脏骤停 (CA),心肺复苏 (CPR) 和TTM的体内大鼠模型.
- 实验室细胞模型用于研究心肌I/R损伤.
- 评估血液动力学功能,心肌损伤,线粒体功能,氧化应激标志物,脂质过氧化和铁水平.
- 对ferritinophagy,ferroptosis和Nrf2通路激活的分析.
主要成果:
- 与老鼠的36°C相比,在33°C的TTM显著改善了复苏后的血液动力学和心肌功能.
- 33°C的TTM和DFO治疗都减少了心肌和线粒体损伤,氧化应激,脂质过氧化和铁过载.
- 低温和DFO抑制了ferritinophagy和ferroptosis,与增强的核转位和Nrf2激活相关.
- Nrf2的激活导致制费里丁和增加铁出口,这表明它在细胞保护中起着关键作用.
结论:
- 在33°C的TTM比36°C更有效地缓解PRMD并通过抑制铁亡来减少心肌损伤.
- 33°C TTM和DFO的保护作用是由Nrf2激活和改善的铁平衡作用.
- 通过铁化和Nrf2信号通路的激活,DFO具有保护作用,为PRMD提供了潜在的治疗策略.
相关概念视频
Increased Body Temperature
636
A body temperature above 38°C (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
636
Methods of reducing fever
640
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
640
Necrosis
4.0K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.0K


